EVEROLIMUS - ANVISA Registration 80254180465
Access comprehensive regulatory information for EVEROLIMUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80254180465 and manufactured by MICROGENICS CORPORATION. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until Mar 25, 2034.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 2 companies making the same product including ROCHE DIAGNOSTICS GMBH, SIEMENS HEALTHCARE DIAGNOSTICS, INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
80254180465
25351637903202396
04930429000139
Company Information
Dates and Status
Mar 25, 2024
25/03/2034
09/18/2025 19:00:01
EVEROLIMUS
Famรญlia Dimension Everolimus (EVRO)
Not specified
10345162463
Mar 20, 2023
EVEROLIMUS
Famรญlia Dimension Everolimus (EVRO)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
10345162463
Mar 20, 2023
EVEROLIMUS
Elecsys Everolimus
Not specified
10287411264
Sep 11, 2017
EVEROLIMUS
Elecsys Everolimus
ROCHE DIAGNOSTICS GMBH
10287411264
Sep 11, 2017
EVEROLIMUS
Famรญlia Elecsys Everolimus
Not specified
10287411167
Oct 24, 2016

